Inhibition of NF-κB and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1945-1958
Author(s):
Ram Ganapathi, Susan A.J. Vaziri, Masahiro Tabata, Nagio Takigawa, Dale R. Grabowski, Ronald M. Bukowski and Mahrukh K. Ganapathi
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1959-1972
Author(s):
S. Brunelleschi, L. Penengo, M. M. Santoro and G. Gaudino
Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
Tissue Transport of Anti-cancer Drugs
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1987-1993
Author(s):
Jan Lankelma
ETS Proteins and MMPs: Partners in Invasion and Metastasis
Journal:
Current Drug Targets
Volume:
3
Page:
359-367
Author(s):
Sadmeet Singh, Jane Barrett, Kenji Sakata, Richard G. Tozer and Gurmit Singh
Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma
Journal:
Current Drug Targets
Volume:
3
Page:
369-378
Author(s):
Ee-Tsin Wong, Yat-Peng Chew, Linda A. Lee and Caroline G.L. Lee
Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Journal:
Current Genomics
Volume:
3
Page:
389-412
Author(s):
M. K. Sauer
STAT Signaling and Cell Function
Journal:
Current Genomics
Volume:
3
Page:
413-423
Author(s):
Fernando de Miguel and Allen C. Gao
Functional Genomics Approaches in Cancer Research
Journal:
Current Genomics
Volume:
3
Page:
425-436
Author(s):
Patrice J. Morin
TGFb and its Smad Connection to Cancer
Journal:
Current Genomics
Volume:
3
Page:
449-476
Author(s):
S. Thiagalingam, K- h. Cheng, R. L. Foy, H. J. Lee, D. Chinnappan and J. F. Ponte